The Safety and Efficacy of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DM
NCT02582814
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
151
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 1 Diabetes Mellitus
Interventions
DRUG:
Dapagliflozin 5 mg
DRUG:
Dapagliflozin 10mg
Sponsor
AstraZeneca